Sector Directory
NanoMed Pty Ltd
NanoMed Pty Ltd is a nanobiotech company based in Sydney, Australia. Our mission is to design, develop and commercialise colloidal nanomedicines for use as cancer therapeutics and diagnostic imaging agents.
National Acoustic Laboratories
National Acoustic Laboratories (NAL) is the clinical research organisation of Hearing Australia specialising in conducting research into Hearing Health care solutions.
National Computational Infrastructure (NCI)
NCI is the leading national institution for high performance computing, and provides world-class high-end services to more than 4,000 Australian researchers from 31 universities, five science agencies and several medical research institutes.
National Health and Medical Research Council
The National Health and Medical Research Council (NHMRC) is Australia’s leading expert body promoting the development and maintenance of public and individual health standards.
Neo-Bionica
Neo-Bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. We offer end-to-end medical device prototype development, from initial concept and rapid prototyping, to pre-clinical testing and first-in-human prototypes for clinical trials.
NeuroScientific Biopharmaceuticals
NeuroScientific Biopharmaceuticals Ltd is an Australian public company developing novel peptide-based pharmaceutical products that target a number of neurological disorders that have high unmet medical needs.
New MedTek Devices Pty Ltd
Based in Sydney Australia, New Medtek Devices Pty Ltd is an early stage medical device technology company focused on the commercialisation of medical devices across the health sector.
NextMed Capital
NextMed Capital's mission is to nurture the seeds of the next generation of medical innovation. The company was founded in 2016 with the goal of becoming Australia's leading very early stage innovation and medical technology investor. NextMed Capital can invest in projects as early as the pre-clinical phase and adds significant value to its investments through leveraging the combined commercial, entrepreneurial, project management, financing, business planning and academic skills of its experienced management team.
NIESM Pty Ltd
Formed in October 2013, NIESM is a Melbourne-based Australian company that delivers clinician support tools focused around wearable technologies and an enterprise software platform to provide optimal health outcomes for patients with epilepsy. NIESM has put together a global team with world leaders in technology, clinical and business capabilities and they are committed to helping patients become seizure free.
NovaCina
NovaCina is a leading supplier of sterile liquid pharmaceutical contract manufacturing services from Perth, Western Australia.
Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies.
Novita Healthcare
Novita Healthcare is an emerging health sector technology company encompassing the current businesses of TALI Health and Newly. The TALI system uses proprietary software algorithms to monitor and assist in the treatment of cognitive problems such as attention difficulties in early childhood.
nRoll Clinical
nRoll is a Virtual Research Site conducting decentralised clinical trials for biotechnology, pharmaceutical and medtech companies. Utilising decentralised methodologies, nRoll is able to offer clinical research opportunities to anyone, anywhere at anytime.
NSW Health's Office for Health and Medical Research
NSW Health’s Office for Health & Medical Research is focused on providing researchers, clinicians, managers and policy makers with the tools they need to translate research into innovative policy and practice to create healthier communities and deliver better patient care in NSW.
Nucleus Network
Nucleus Network is a leading early phase clinical research organisation in Australia, providing an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.